Skip to main content
Log in

Strain selection, medium development and scale-up of toyocamycin production by streptomyces chrestomyceticus

  • Originals
  • Published:
Bioprocess Engineering Aims and scope Submit manuscript

Abstract

The batch productivity (Q TM) of the production of the nucleoside antibiotic toyocamycin (TM) by Streptomyces chrestomyceticus was increased ten-fold by selection of a UV generated mutant, optimization of pH, increasing incubation temperature from 28 °C to 36 °C, and addition of soy oil. Initial high oxygen transfer rates stimulated Q TM maxima two-fold. Antibiotic production by the mutant strain, U190, however, appeared more shear sensitive than the parent culture FCRF 341 with maximum antibiotic titer being inversely related to impellor tip velocity, T v . For this reason, scale-up could not be done at constant P/V or constant volumetric oxygen transfer. Instead, programming of impeller speed was evaluated in order to maintain optimal impeller tip velocity during scale-up. It was found that a low constant T v maintained in scale-up in geometrically similar vessels was most beneficial for duplication of optimal antibiotic productivity, Q TM. Pilot fermentations (120 dm3 scale) were used to determine coefficients of Q TM variation from oxygen uptake rate (OUR) and total CO2 evolution data for monitoring of Q TM variation during scale-up to the 12,000 dm3 scale. This technique allowed for on-line prediction of antibiotic titer and Q TM from fermentor exhaust gas data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

A :

scale constant

B :

shape constant

C :

location of maximum constant

D m:

impeller diameter (m)

H m:

liquid height (m)

OTR MmolO2·(dm3)−1min−1 :

oxygen transfer rate

OUR MmolO2·(dm3)−1min−1 :

oxygen uptake rate

PCV cm3 :

packed cell volume

P/V watts/dm3 :

volumetric power consumption

Q 1 · min−1 corrected to standard conditions of temperature, pressure:

aeration rate

Q TM μg/(cm3 · h) or kg/(m3 · h):

antibiotic productivity

T m:

tank diameter

T mix s:

mixing time

T v cm · s−1 :

impeller tip velocity

TM μg/cm3 :

Toyocamycin concentration

TNP :

Tricyclic nucleoside phosphate

References

  1. Kuenzi, M. T.: Process design and control in antibiotic fermentations. In: Hutter, R.; Leisinger, T.; Nuesch, J.; Wehrli, W. (Ed.): Antibiotics and Other Secondary Metabolites — Biosynthesis and Production, pp. 39–56. New York: Academic Press 1978

    Google Scholar 

  2. Bylinkira, E. S.; Bikukov, V. V.: The problem of scale-up in antibiotic biosynthesis. Proc. IV IFS: Ferment. Technol. Today (1972) 105–115

  3. Young, T. B.; Koplove, H. M.: A systems approach to design and control of antibiotic fermentation. Proc. IV IFS: Ferment. Technol. Today (1972) 163–166

  4. Oldshue, J. Y: How to keep “funny things from happening” when a fermenter is scaled up. Proceedings of the American Chemical Society's Annual Meeting. MBT Division, Sept. 1979

  5. Banks, G. T.: Scale-up of fermentation processes. In: Wiseman, A. (Ed.): Topics in Enzyme and Fermentation Biotechnology, pp. 170–266. John Wiley and Sons 1979

  6. Miura, Y: Transfer of oxygen and scale-up in submerged aerobic fermentation. Adv. Biochem. Eng. 4 (1976) 3–40

    Google Scholar 

  7. Jain, D.; Buckland, B. C.: Scale-up of the efrotomycin fermentation using a computer controlled pilot plant. Biopr. Eng. 3 (1988) 31–36

    Google Scholar 

  8. Hirose, Y.; Enei, H.; Shibai, H.: Nucleosides and nucleotides. In: Perlman, D. (Ed.): Annual reports on fermentation processes, vol. 3, pp. 253–274. Academic Press 1979

  9. Nakao, Y.: Microbial production of nucleosides and nucleotides. In: Peppler, H. J.; Perlman, D. (Eds.): Microbial technology, vol. 1, pp. 312–354. Academic Press 1979

  10. Schadolnik, R. J.; Uematsu, T.: Biosynthesis of the pyrrolopyrimidine nucleoside antibiotic toyocamycin VII. Origin of the pyrrole carbons and the cyano carbon. J. Biol. Chem. 245 (1970) 4365–4371

    Google Scholar 

  11. Nishimara, H.; Katagiri, K.; Sato, K.; Mayama, M.; Shimaoka, N.: Toyocamycin, a new anti-candida antibiotic S. J Antibiotics Sec. A9. 2 (1956) 60–62

    Google Scholar 

  12. Rao, K. V; Brook, P.; Marsh, W. S.; Renn, W.; Ren, D. W.: U.S. Patent 3, 116, 221. Dec. 31, 1963

  13. Ohkurma, K.: Chemical structure of toyocamycin. J Antibiotics. 14 (1961) 343–352

    Google Scholar 

  14. Kominek, L. A.: Biosynthesis of novobiocin by Streptomyces niveus. Antimicrobial Agents Chemotherapy. 1 (1972) 123–134

    Google Scholar 

  15. Forrest, E. H.; Jansen, N. B.; Flickinger, M. C.; Tsao, G. T.: A simple hobby computer-based off gas analysis system. Biotechnol. Bioeng. 23 (1981) 455–460

    Google Scholar 

  16. Elstner, E. F.; Suhadolnik, R. J.: The biosynthesis of the nucleoside antibiotics IX. Purification and properties of guanosine triphosphate 8-formylhydrolase that catalyzes production of formic acid from the ureido carbon of guanosine triphosphate. J. Biol. Chem. 246 (1971) 6973–6981

    Google Scholar 

  17. Suhadolnik, R. J.; Uematsu, T.: Biosynthesis of pyrrolopyrimidine nucleoside antibiotic toyocamycin. J. Biol. Chem. 245 (1970) 4365–4371

    Google Scholar 

  18. Martin, J. F; Demain, A. L.: Control of antibiotic biosynthesis. Microbial Revs. 44 (1980) 230–251

    Google Scholar 

  19. Weinberg, D.: Regulation by phosphate and trace elements. Folia Microbiol. 23 (1978) 496–504

    Google Scholar 

  20. Martin, J. F; Naharro, G.; Liras, P.; Villanueva, J. R.: Isolation of mutants deregulated in phosphate control of candicidin biosynthesis. J. Antibiotics. 32 (1979) 600–606

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flickinger, M.C., Greenstein, M., Bremmon, C. et al. Strain selection, medium development and scale-up of toyocamycin production by streptomyces chrestomyceticus. Bioprocess Engineering 5, 143–153 (1990). https://doi.org/10.1007/BF00369578

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00369578

Keywords

Navigation